SEC Form 4 · accession 0001573202-17-000005
RespireRx Pharmaceuticals Inc. · RSPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeff Eliot Margolis
Officer — VP, Treasurer and Secretary · Director
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 9:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000849636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options (to purchase shares of Common Stock)F6,F1 | $2.00 | Jun 30, 2017 | A | 30,000 | A | — | Jun 30, 2022 | common stock | 30,000 | 30,000 | I |
| Common Stock Options (to purchase shares of Common Stock)F1 | $2.00 | Jun 30, 2017 | A | 20,000 | A | — | Jun 30, 2022 | common stock | 20,000 | 20,000 | I |
| Common Stock Options (to purchase shares of Common Stock)F3,F2 | $3.90 | holding | — | — | — | — | Jan 18, 2022 | common stock | 35,000 | 35,000 | I |
| Common Stock Options (to purchase shares of Common Stock)F5,F2 | $3.90 | holding | — | — | — | — | Jan 18, 2022 | common stock | 15,000 | 15,000 | I |
| Common Stock Warrants (right to buy)F7,F3,F8 | $6.9225 | holding | — | — | — | — | Sep 30, 2020 | common stock | 2,423 | 2,423 | I |
| Common Stock Warrants (right to buy)F7,F5,F8 | $6.9225 | holding | — | — | — | — | Sep 30, 2020 | common stock | 2,423 | 2,423 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F3,F9 | $7.3775 | holding | — | — | — | — | Mar 31, 2021 | common stock | 40,000 | 40,000 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F4,F9 | $7.3775 | holding | — | — | — | — | Mar 31, 2021 | common stock | 6,154 | 6,154 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F6,F9 | $7.3775 | holding | — | — | — | — | Mar 31, 2021 | common stock | 21,539 | 21,539 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F5,F9 | $7.3775 | holding | — | — | — | — | Mar 31, 2021 | common stock | 6,154 | 6,154 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F3,F10 | $6.396 | holding | — | — | — | — | Aug 18, 2022 | common stock | 13,847 | 13,847 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F4,F10 | $6.396 | holding | — | — | — | — | Aug 18, 2022 | common stock | 7,693 | 7,693 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F6,F10 | $6.396 | holding | — | — | — | — | Aug 18, 2022 | common stock | 7,693 | 7,693 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F5,F10 | $6.396 | holding | — | — | — | — | Aug 18, 2022 | common stock | 1,539 | 1,539 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F3,F11 | $8.125 | holding | — | — | — | — | Jun 30, 2022 | common stock | 24,616 | 24,616 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F4,F11 | $8.125 | holding | — | — | — | — | Jun 30, 2022 | common stock | 6,154 | 6,154 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F6,F11 | $8.125 | holding | — | — | — | — | Jun 30, 2022 | common stock | 13,847 | 13,847 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F5,F11 | $8.125 | holding | — | — | — | — | Jun 30, 2022 | common stock | 1,539 | 1,539 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F12 | $16.25 | holding | — | — | — | — | Jul 17, 2019 | common stock | 6,994 | 6,994 | D |
| Common Stock Options (to purchase shares of Common Stock)F7,F3,F12 | $16.25 | holding | — | — | — | — | Jul 17, 2019 | common stock | 3,077 | 3,077 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F4,F12 | $16.25 | holding | — | — | — | — | Jul 17, 2019 | common stock | 1,119 | 1,119 | I |
| Common Stock Options (to purchase shares of Common Stock)F7,F5,F12 | $16.25 | holding | — | — | — | — | Jul 17, 2019 | common stock | 4,196 | 4,196 | I |
Explanation of responses
- F1These awards were made to the reporting person or his designee and were issued to Trusts or his spouse at his direction for estate planning purposes. These Common Stock Options vested upon issuance.
- F10These Common Stock Options vested in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016, and are all currently vested.
- F11These Common Stock Options vested in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015, and are all currently vested and exercisable.
- F12These Common Stock Options vested in three equal installments on July 17, 2014, September 30, 2014 and December 31, 2014, and are all currently vested.
- F2These Common Stock Options vested in three installments: 25 percent on January 18, 2017 (the grant date), 25 percent on March 31, 2017, and 50 percent on June 30, 2017, and are all currently vested.
- F3These securities are held in a trust for the benefit of Mr. Margolis's spouse. Mr. Margolis is a trustee of the trust.
- F4These securities are held in trusts for the benefit of Mr. Margolis's children. Mr. Margolis's spouse is a trustee of these trusts. Mr. Margolis disclaims beneficial ownership of these securities, and the filing of this report is not an admission that Mr. Margolis is the beneficial owner of these securities for purposes of Section 16 or any other purpose.
- F5These securities are held in trusts for the benefit of Mr. Margolis's children. Mr. Margolis is a trustee of these trusts. Mr. Margolis disclaims beneficial ownership of these securities, and the filing of this report is not an admission that Mr. Margolis is the beneficial owner of these securities for purposes of Section 16 or any other purpose.
- F6These securities are held in a trust for the benefit of Mr. Margolis. Mr. Margolis's spouse is a trustee of the trust.
- F7The exercise price and number of shares of these securities have been adjusted to reflect the Company's 325-to-1 reverse stock split effective September 1, 2016.
- F8These Warrants were acquired by Mr. Margolis and his spouse in his capacity as President of Aurora Capital LLC, which served as placement agent in the Company's unit offering with each unit consisting of one share of common stock and warrants to purchase two additional shares of common stock, and represent his share of the Placement Agent Warrants awarded at each closing of that transaction. The warrants are currently exercisable.
- F9These Common Stock Options vested in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016, and are all currently vested.